Advanced Active Chemical Threat Scanning System
The world's most advanced active trace detection analyzer. TRU-RAD Dual Axial IMS with DDMS adaptive intelligence. The integration hub for the complete AACTS® ecosystem — deployed across defense, aviation, healthcare, and industrial domains.
The AACTS-3000 combines active high-volume sampling, patented dual-axial drift tube design, and adaptive detection intelligence into a single integrated platform — capable of operation across defense, border security, healthcare, and industrial applications without hardware changes.
| Detection Performance | |
|---|---|
| Analysis Time | <20 seconds Full compound identification per cycle |
| Detection Sensitivity | ng–pg range Nanogram to picogram |
| IMS Architecture | TRU-RAD Dual Axial (X-AIMS) Patented orthogonal configuration |
| Ionization Source | Ni-63 (AERB licensed) |
| Detection Modes | E / N / Combined / VOC DDMS-adaptive · Real-time switching |
| System Architecture | |
|---|---|
| Analyzer Interface | Real-time spectral display On-screen drift-time visualization |
| User Access | Role-based (3 tiers) Operator / Superuser / Admin |
| Sampling Integration | HVS + HHS + Breath All modes via filter card interface |
| Compound Library | Multi-domain · Expandable Software updates · Custom domains |
| Manufacturing | AMTZ Visakhapatnam, India ISO 13485-aligned · Make in India |
Central detection unit. Houses TRU-RAD X-AIMS IMS engine, DDMS algorithm, spectral display, compound library, and data management. Accepts all filter card formats.
Wide-area aspiration at ~1,500 L/min. Containers, vehicle interiors, aircraft cabins, open checkpoints. Sample via filter card to analyzer.
Portable battery-operated precision sampling. Targeted surfaces, objects, personnel. ~100–150 L/min. Field-deployable without fixed infrastructure.
Reusable SPME-coated wire-mesh media. ~0.2 µm filtration. Universal transfer between all samplers and the analyzer. Up to 20 reuse cycles.
Thermal regeneration unit. ~5 min cycle. Multi-card processing. Removes residual analytes to restore adsorption capacity.
Healthcare extension for non-invasive VOC biomarker capture. 7–10 expirations. No reagents. Validated for TB screening (95.7% sensitivity).
Contact our technical team for a live demonstration, capability briefing, or pilot deployment assessment for your operational environment.